$MKZR Cashflow Statement | Understand Stock

$MKZR

$1.12 -$0.02 (1.75%) Close

$MKZR Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Cash Flows

In millions of USD, except per-share amounts

	FY2026 12 months to Jun 30, 2026	FY2025 12 months to Jun 30, 2025	FY2024 12 months to Jun 30, 2024	FY2023 12 months to Jun 30, 2023	FY2022 12 months to Jun 30, 2022
Cash flows from operating activities:
Net loss
Adjustments to reconcile net loss to net cash from operating activities:
Net unrealized gain on equity securities at fair value
Net income from equity method investments at fair value
Net (income) loss from equity method investments at fair value
Net realized gain on investments
Net loss on disposal of fixed assets
Net loss on disposal of real estate
Impairment loss on assets held for sale
Gain on extinguishment of debt
Impairment loss
Straight-line rent
Depreciation and amortization
Accretion of market lease and other intangibles, net
Amortization of deferred financing costs and debt mark-to-market
Accretion of above (below) market lease, net
Stock-based compensation
Changes in assets and liabilities:
Investments income, rents and other receivables
Due from related entities
Prepaid expenses and other assets
Deferred rent and other liabilities
Accounts payable and accrued liabilities
Due to related entities

Net cash from operating activities
Cash flows from investing activities:
Proceeds from sale of investments
Investment acquisition advance
Net proceeds from sale of real estate
Investments in real estate assets
Purchase of investments
Return of capital distributions
Payment on contingent liability
Net cash from investing activities
Cash flows from financing activities:
Borrowing under mortgage notes payable
Payments on mortgage notes payable
Borrowing under line of credit
Proceeds from notes payable
Payments on notes payable
Payment of financing fees
Dividends to common stockholders
Dividends to preferred stockholders
Series A Preferred Stock
Series B Preferred Stock
Series C Preferred Stock
Proceeds from issuance of preferred stock
Series A Preferred Stock
Series B Preferred Stock
Series C Preferred Stock
Total proceeds from issuance of preferred stock

Proceeds from issuance of common stock
Proceeds from issuance of pre-funded warrants
Proceeds from issuance of common stock warrants
Series A Common Stock
Series B Common Stock
Payment on finance lease liabilities
Payment of selling commissions and fees
Contributions by non-controlling interests holders
Distributions to non-controlling interests holders
Redemptions of common stock
Redemption of preferred stock
Redemption of preferred stock, net of stock redemption payable
Redemptions of preferred stock
Series A Preferred Stock
Series B Preferred Stock
Capital pending acceptance
Net cash from financing activities

Net decrease in cash, cash equivalents and restricted cash
Cash, cash equivalents and restricted cash at beginning of the year
Cash, cash equivalents and restricted cash at end of the year
Cash and cash equivalents at end of the year
Restricted cash at end of the year
Cash at end of the year classified as assets held for sale
Total cash, cash equivalents, restricted cash and cash classified as held for sale at end of the year
Supplemental disclosure of non-cash financing activities and other cash flow information:
Issuance of preferred stock through reinvestment of dividends
Series A Preferred Stock
Series B Preferred Stock
Series C Preferred Stock
Total issuance of preferred stock through reinvestment of dividends

Increase in liquidation preference of Series B preferred stock
Issuance of Operating Partnership Preferred Units - Series A through reinvestment of dividends
Series A Preferred Stock
Total issuance of Operating Partnership Preferred Units - Series A through reinvestment of dividends
Cash paid for interest
Increase in liquidation preference of Operating Partnership Preferred Units - Series B
Preferred Series conversion to common stock
Series A Preferred Stock
Series B Preferred Stock
Conversion of Series B preferred stock liquidation preference (9% non-cash dividend) to common stock
Conversion of Operating Partnership Series A Preferred Units to common stock
Reclassification of prepaid expenses and other assets to mortgage notes payable, net
Capitalized construction in progress outstanding as accounts payable and accrued expenses
Issuance of the Operating Partnership Preferred Units for the purchase of Green Valley Medical Center, LP (Note 1)
GV Executive Center, LLC
One Harbor Center, LP
First & Main, LP
Main Street West, LP
Green Valley Medical Center, LP
Fair value of assets acquired from consolidation of Green Valley Medical Center, LP
GV Executive Center, LLC
One Harbor Center, LP
First & Main, LP
Main Street West, LP
1300 Main, LP
Woodland Corporate Center Two, LP
Green Valley Medical Center, LP
Fair value of liabilities assumed from consolidation of Green Valley Medical Center, LP
GV Executive Center, LLC
One Harbor Center, LP
First & Main, LP
Main Street West, LP
1300 Main, LP
Woodland Corporate Center Two, LP
Green Valley Medical Center, LP
Issuance of the Operating Partnership Class A units for the purchase of real estate assets (Note 5)
Issuance of the Operating Partnership Preferred units for the purchase of investments (Note 5)
Issuance of common stock for merger of FSP Satellite Place Corp. (Note 1)
Issuance of preferred stocks for merger of FSP Satellite Place Corp. (Note 1)
Fair value of subsidiary's units owned prior to the merger date
Reduction in contingent consideration estimate
Stock-based compensation
Operating Partnership Class A conversion to common stock
Conversion of notes receivable to preferred equity of Martin Plaza Associates, LP
Issuance of common stock through reinvestment of dividends

Comments